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Characterization of group B streptococcus (GBS) strains
isolated from neonatal invasive diseases in Belgium, 2015. 
OBJECTIVES 
Early-onset and Late-onset Diseases (EOD, LOD)
Despite advances in preventive strategies, Group B
Streptococcal (GBS) disease is still a leading cause of
severe neonatal infections. The Belgian National
Reference Centre (NRC) routinely performs
surveillances of GBS invasive strains.
To provide an overview of bacteriological
characteristics of GBS causing early and late onset
invasive diseases in infants during the year 2015, in
Belgium.
• To characterize relevant epidemiological
markers of the isolated GBS strains.
• Determination of their capsular-
polysaccharide (CPS) types and distribution.
• Determination of their pili types and
distribution.
• Determination and description of their
antimicrobial susceptibility profile.
• Determination and distribution of macrolide




§ In Belgium, GBS invasive disease is not a notifiable disease. Surveillance is organized by the NRC and strains are provided by Belgian
laboratories belonging to a surveillance network. During the last decade, number of participating laboratories has increased impacting
the number of reported cases.
§ Bacteriological characteristics of GBS isolated from newborns with invasive disease (early and late-onset), CPS type distribution, pili
type distribution, rate and type of resistance to macrolide/lincosamide, were consistent with reported data among European countries
and North America.

















• Multiplex	PCR	for	ErmB,	ErmTr,	MefA and	LSaC genes	
Population:
• Overall during the year 2015, on a voluntary base, laboratories
belonging to the national surveillance network sent to the NRC
a total of 44 GBS strains isolated from bloodculture or cerebro-
spinal fluid of newborns with invasive disease.









Distribution of CPS types and pili types
• A CPS type was assigned to all isolates:
• The most prevalent CPS type was type III either among EOD cases (43.3%) or LOD cases (65.4%).
See Figure 2.
• Every isolate of GBS harboured at least one pili gene or a combination of genes.
• Pili genes were not evenly distributed among strains isolated from EOD or LOD. See Figure 3.
• Among the EOD cases, the pili genes PI2a (33.3%) and the combination PI1,PI2a (33.3%) were
predominant, closely followed by PI1, PI2b (23.8%).
• Among the LOD cases, strains harboured mainly the combination of pili genes PI1,PI2b (45.8%).
Figure 1: Overview of the 
yearly distribution of GBS 
EOD and LOD cases (2002 –
2015).
§ Susceptibility to beta-lactams
• All isolates were fully S to penicillin with MICs ranging from 0.03 to 0.125 mg/L.
• According to Kimura’s procedure and interpretative criteria, no decreased
susceptibility to beta-lactams was detected.
§ Susceptibility to macrolide-lincosamide
• Out of 44 isolates, 10 (22%) were resistant to erythromycin and clindamycin.
• As shown in Figure 4 the major phenotype of resistance was cMLS (90% of
resistant isolates), the constitutive resistant phenotype. The inducible, iMLS,
phenotype was demonstrated in one resistant GBS; no isolate showed isolated
resistance to erythromycin (M phenotype) or the L phenotype, isolated resistance
to clindamycin).
• The distribution of the genes coding for resistance, ErmB, ErmTr, MefA and LsaC
harboured by these 10 isolates is shown in the following Figure 5.
Figure 5: Distribution of the resistance genes to macrolide-lincosamide
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Figure 3: Distribution of the pili genotypes of 44 
GBS strains isolated in 2015 from newborns with 
invasive disease: 21 EOD and 23 LOD
Figure 2: Distribution of CPS types of 44 GBS strains 
isolated in 2015 from newborns with invasive disease: 
21 EOD and 23 LOD
Figure 4: Distribution of resistance 
phenotypes to macrolide-lincosamide among 




• A total of 44 GBS strains isolated from neonatal invasive diseases received by the NRC in 2015: 21
from EOD and 23 from LOD, see Figure 1, year 2015.
• Considering the incidence of GBS neonatal infections in Belgium, this collection represented for
2015 about 40% of GBS invasive diseases. Not shown, through the past decade, the number of
laboratories participating has more than doubled, and therefore the number of reported cases.
• The ratio between EOD and LOD has evolved these recent years, EOD cases were higher than LOD
in the beginning of the 21th century. In 2015, the number of LOD cases was higher than EOD,
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